Dissemin is shutting down on January 1st, 2025

Published in

Bentham Science Publishers, Current Pharmaceutical Design, 32(18), p. 4950-4959

DOI: 10.2174/138161212802884807

Links

Tools

Export citation

Search in Google Scholar

Why do Psychotic Patients use Cannabis? Case Series

Journal article published in 2012 by Anna Kolliakou, Khalida Ismail ORCID, Zerrin Atakan
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The rate of substance use, particularly cannabis, among patients with psychosis is high and much greater than in the general population. Persistent cannabis use by patients with an established psychotic disorder adversely affects prognosis and recovery. Little agreement has been reached on the reasons that sustain cannabis use in patients with psychosis although self-report studies have shown that patients appear to use cannabis largely for the same reasons as the general population i.e. to 'get high' or reduce negative states such as depression and boredom. The aim of this series is to explore 5 individual cases of patients with psychosis reporting cannabis use. Full clinical assessment for each patient as well as cannabis use history, reasons for use and implications for effective treatment are explored.